Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: J Surg Oncol. 2016 Apr;113(5):473–476. doi: 10.1002/jso.24181

Table 2.

Univariable & Multivariable analysis of 302 patients with Sporadic Metastatic Colorectal Cancer.

Number Univariable Analysis Multivariable Analysis
Factor 5 year survival P value Hazard Ratio 95% Confidence Intervals P value
Extrahepatic disease: Yes 154 12% <0.001 1.00 0.73 – 1.39 0.96
         No 148 28%
Before 2000 123 7% <0.001 1.55 1.19 – 2.01 0.001
After 2000 179 28%
Gender: Male 131 14% 0.78
    Female 171 24%
Site of primary tumor: Rectum 66 16% 0.12
         Left colon 153 24% 0.91 0.62 – 1.33 0.64
         Right colon 82 15% 0.90 0.66 – 1.21 0.48
KRAS mutant: Yes 19 31% 0.02
      No 37 54%
HAIP Chemotherapy: Yes 79 30% <0.001 0.97 0.67 – 1.41 0.94
         No 223 15%
Liver resection: Yes 103 43% <0.001 3.65 2.52 – 5.28 <0.001
      No 197 7%
Resection of primary tumor: Yes 249 23% <0.001 2.01 1.40 – 2.88 <0.001
           No 52 0%
Nodal disease in primary tumor: Yes 201 22%
             No 36 34%
Pregnant at Diagnosis: Yes 21 26% 0.42
          No 281 19%
Inflammatory bowel disease: Yes 14 14% 0.10
           No 288 20%